Inactive Instrument
Agile Therapeutics, Inc. Stock
Stocks
AGRX
US00847L3087
Biotechnology & Medical Research
OTC Markets Traded| Manager | Title | Age | Since |
|---|---|---|---|
Robert Spina
CEO | Chief Executive Officer | - | 2024-08-25 |
| Corporate Secretary | - | 2024-08-25 |
| Director | Title | Age | Since |
|---|---|---|---|
Salustiano Pérez
CHM | Chairman | - | 2024-08-25 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/26/24 | Issuer sale | Director | 976 | 0.0142% | ||
| 8/26/24 | Issuer sale | Chief Administrative Officer | 20,256 | 0.2954% | ||
| 8/26/24 | Issuer sale | Chief Financial Officer | 20,080 | 0.2929% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | +3.42% | - | - | 10.43M | |
| -3.19% | -3.19% | +44.60% | +87.98% | 74.68B | |
| -15.86% | -16.67% | +3.92% | +50.90% | 58.7B | |
| -2.39% | -2.05% | +4.29% | +31.33% | 48.36B | |
| -6.35% | -8.35% | +303.95% | +651.28% | 43.05B | |
| +0.30% | -3.71% | +28.89% | +30.33% | 42.48B | |
| -3.82% | -4.32% | +2.49% | +101.36% | 41.39B | |
| -2.13% | +1.07% | +7.51% | +50.31% | 31.29B | |
| -3.35% | -6.35% | -13.20% | -17.22% | 23.93B | |
| -1.24% | -11.97% | -38.10% | +311.13% | 22.22B | |
| Average | -3.80% | -2.63% | +38.26% | +144.16% | 42.9B | |
| Weighted average by Cap. | -4.86% | -1.88% | +44.70% | +136.42% |
Employees
19
